GRAIL, Inc. (GRAL)
95.96
-4.44
(-4.42%)
USD |
NASDAQ |
Feb 12, 16:00
95.00
-0.96
(-1.00%)
After-Hours: 20:00
GRAIL EPS Diluted (Quarterly) : -2.463 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| Interpace Biosciences, Inc. | 0.0329 |
| Thermo Fisher Scientific, Inc. | 5.21 |
| XWELL, Inc. | -0.2557 |
| Hypha Labs, Inc. | -0.0038 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -88.98M |
| Revenue (Quarterly) | 36.19M |
| Total Expenses (Quarterly) | 125.17M |
| Enterprise Value | 3.432B |
| Gross Profit Margin (Quarterly) | -47.91% |
| Profit Margin (Quarterly) | -245.8% |
| Earnings Yield | -12.10% |
| Normalized Earnings Yield | -11.54 |